Otsuka

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

Axsome increases Auvelity's peak sales projection to $8B

May 5, 2026 11:48am

Axsome's Auvelity wins FDA expansion for Alzheimer's agitation

May 1, 2026 11:42am

Drug tariffs, Takeda, Lilly-Insilico—Fierce Pharma Asia

Apr 3, 2026 7:49am

Lilly-Innovent, AstraZeneca, Madrigal—Fierce Pharma Asia

Feb 13, 2026 8:25am

Otsuka awareness campaign urges HCPs to see 'All of ADHD'

Feb 9, 2026 12:22pm